25 May 2013
Keywords: uk, nice, recommends, roche, mabthera, national, institute
Article | 29 September 2003
The National Institute for Clinical Excellence has said that Roche's MabThera (rituximab) should be made available under the National Health
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
29 September 2003
24 May 2013
© 2013 thepharmaletter.com